Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jul;33(7):1443-8.
doi: 10.2337/dc09-2297. Epub 2010 Mar 31.

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes

Affiliations
Randomized Controlled Trial

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes

Markus Walter et al. Diabetes Care. 2010 Jul.

Abstract

Objective: To determine whether daily intake of 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] is safe and improves beta-cell function in patients with recently diagnosed type 1 diabetes.

Research design and methods: Safety was assessed in an open study of 25 patients aged 18-39 years with recent-onset type 1 diabetes who received 0.25 microg 1,25(OH)(2)D(3) daily for 9 months. An additional 40 patients were randomly assigned to 0.25 microg 1,25(OH)(2)D(3) or placebo daily for 9 months and followed for a total of 18 months for safety, beta-cell function, insulin requirement, and glycemic control.

Results: Safety assessment showed values in the normal range in nearly all patients, regardless of whether they received 1,25(OH)(2)D(3) or placebo. No differences in AUC C-peptide, peak C-peptide, and fasting C-peptide after a mixed-meal tolerance test between the treatment and placebo groups were observed at 9 and 18 months after study entry, with approximately 40% loss for each parameter over the 18-month period. A1C and daily insulin requirement were similar between treatment and placebo groups throughout the study follow-up period.

Conclusions: Treatment with 1,25(OH)(2)D(3) at a daily dose of 0.25 microg was safe but did not reduce loss of beta-cell function.

Trial registration: ClinicalTrials.gov NCT00960635.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of participants. A: Participation in the open study designed to assess safety of 1,25(OH)2D3 (n = 25). B: Random assignment into the phase II, randomized, double-blind, placebo-controlled study to assess efficacy of study drug (n = 22 study drug, n = 18 placebo).
Figure 2
Figure 2
Safety parameters. Plasma calcium concentrations (A) and 24-h urinary calcium excretion values (B) for patients who received study drug (n = 47, ■) and patients who received placebo (n = 18, □) over 18 months of follow-up. Data are means ± SEM. The reference calcium plasma levels (2.1–2.6 mmol/l) and urine secretion (<10 mmol/24 h) are indicated by the dotted line. VitD3, 1α,25-dihydroxyvitamin D3.
Figure 3
Figure 3
Efficacy parameters. Fasting (A) and AUC C-peptide after mixed-meal stimulation (B), mean A1C (C), and mean insulin requirement per kilogram body weight (D) in the 1,25(OH)2D3 treatment group (■) and the placebo group (□). Data are means ± SEM. VitD3, 1α,25-dihydroxyvitamin D3.

Similar articles

Cited by

References

    1. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358: 221–229 - PubMed
    1. Staeva-Vieira T, Peakman M, von Herrath M: Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 2007; 148: 17–31 - PMC - PubMed
    1. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The Eurodiab Substudy 2 Study Group. Diabetologia 1999; 42: 51–54 - PubMed
    1. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM: Intake of vitamin D and risk of type 1 diabetes; a birth-cohort study. Lancet 2001; 358: 1500–1503 - PubMed
    1. Zipitis CS, Akobeng AK: Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008; 93: 512–517 - PubMed

Publication types

MeSH terms

Associated data